search
Company Information
USD
254.14
- (-1%)
NYSE:DHR, DANAHER CORPORATION
Industry: Diagnostics & Research
End of Day: 25 June 2024 GMT-4
In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Address

2200 Pennsylvania Avenue, N.W.
Suite 800W

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. Walter G. Lohr, Jr
Director
Mr. Alan G. Spoon, J.D.
Director
Mr. Joakim Weidemanis
Executive VP
Ms. Linda Hefner Filler
Director
Mr. John T. Schwieters
Director
Mr. Mitchell P. Rales
Co-Founder/Director
Mr. Steven M. Rales
Chairman of the Board/Co-Founder/Director
Mr. Daniel A. Raskas
Senior VP, Divisional
Dr. Elias A. Zerhouni, M.D.
Director
Ms. Teri L. List-Stoll
Director
Mr. Matthew R. McGrew
CFO/Executive VP
Mr. William H. King
Senior VP, Divisional
Mr. Rainer M. Blair
CEO/Director/President
Mr. Brian W. Ellis
General Counsel/Senior VP
Dr. Jose-Carlos Gutierrez-Ramos, PhD
Chief Scientific Officer/Senior VP
Mr. Feroz Dewan
Director
Professor Raymond C. Stevens, PhD
Director
Dr. Jessica L. Mega, M.D.,M.P.H.
Director
Dr. Pardis C. Sabeti, M.D.
Director
Mr. A. Shane Sanders
Director
Mr. Christopher M. Bouda
Chief Accounting Officer/Vice President
Ms. Georgeann F. Couchara
Senior VP, Divisional
Mr. Christopher Paul Riley
Executive VP

Ownership

Institution Holdings

Vanguard Group Inc
55,943,373 (7.563%)
BlackRock Inc
50,772,596 (6.864%)
Wellington Management Company LLP
27,928,442 (3.776%)
State Street Corporation
27,509,575 (3.719%)
Capital Research and Management Company
24,665,732 (3.335%)
Capital Group
22,526,631 (3.045%)
FMR Inc
22,350,888 (3.022%)
Vanguard Investments Australia Ltd
21,275,394 (2.876%)
Fidelity Management & Research Company LLC
21,030,901 (2.843%)
Morgan Stanley - Brokerage Accounts
19,654,901 (2.657%)

Individual Holdings

Mr. Steven M. Rales
4,355,808 (0.591%)
Mr. Mitchell P. Rales
1,590,844 (0.216%)
Mr. Rainer M. Blair
125,000 (0.017%)
Mr. Alan G. Spoon, J.D.
108,075 (0.015%)
Mr. Joakim Weidemanis
90,412 (0.012%)
Mr. Matthew R. McGrew
50,610 (0.007%)
Mr. William H. King
42,585 (0.006%)
Ms. Linda Hefner Filler
38,152 (0.005%)
Mr. Daniel A. Raskas
38,102 (0.005%)
Mr. Brian W. Ellis
33,830 (0.005%)

Funds Holdings

Vanguard US Total Market Shares ETF
20,905,889 (2.826%)
Vanguard Total Stock Market Index Fund
20,905,889 (2.826%)
Vanguard Institutional 500 Index Trust
16,253,118 (2.197%)
Fidelity 500 Index Fund
7,808,062 (1.056%)
SPDR® S&P 500 ETF Trust
7,721,092 (1.044%)
Vanguard Dividend Growth Fund
7,080,562 (0.957%)
iShares Core S&P 500 ETF
6,841,963 (0.925%)
Vanguard Value Index Fund
5,535,731 (0.748%)
Vanguard Wellington™ Fund
5,246,678 (0.709%)
Health Care Select Sector SPDR® Fund
4,981,459 (0.673%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices